Related Experiment Video

Updated: May 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Influence of statin treatment on mortality of patients with myocardial infarction

Z Vincze1, B Brugos

  • 1Emergency Department, Division of Clinical Immunology, University of Debrecen, Hungary.

Die Pharmazie
|July 7, 2012
PubMed

Insights

Early statin therapy significantly reduces mortality in acute myocardial infarction (AMI) patients. While cholesterol levels didn't correlate with mortality, prompt statin use after AMI is crucial for better outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Dyslipidemia, particularly elevated LDL cholesterol, is a key risk factor for cardiovascular diseases like atherosclerosis and ischemic heart disease.
  • Early intervention with cholesterol-lowering drugs post-acute myocardial infarction (AMI) is linked to reduced complications such as cardiogenic shock and recurrent infarction.

Purpose of the Study:

  • To evaluate the impact of statin therapy on mortality in patients hospitalized with AMI.
  • To investigate the correlation between serum lipid parameters and mortality in AMI patients.

Main Methods:

  • Retrospective analysis of data from 416 patients admitted with AMI over a two-year period (2001-2003).
  • Focus on the administration and timing of statin therapy.
  • Comparison of mortality rates between patients receiving and not receiving statin treatment post-AMI.

Main Results:

  • No significant correlation was found between serum lipid levels and mortality in AMI patients.
  • Pre-AMI chronic statin use did not significantly influence patient mortality.
  • Patients with ST-elevation myocardial infarction (STEMI) exhibited significantly higher cholesterol levels (p=0.043).
  • Mortality was significantly higher in patients who did not receive statin treatment after AMI.

Conclusions:

  • Early and aggressive statin treatment following AMI is essential for improving patient survival.
  • Statins are necessary for managing hypercholesterolemia and reducing cardiovascular risk in AMI patients.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...